Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial

BACKGROUND: The subcutaneous (S) implantable cardioverter-defibrillator (ICD) is safe and effective for sudden cardiac death prevention. However, patients in previous S-ICD studies had fewer comorbidities, had less left ventricular dysfunction, and received more inappropriate shocks (IAS) than in ty...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Circulation
Main Authors: Gold, Michael R., Lambiase, Pier D., El-Chami, Mikhael F., Knops, Reinoud E., Aasbo, Johan D., Bongiorni, Maria Grazia, Russo, Andrea M., Deharo, Jean-Claude, Burke, Martin C., Dinerman, Jay, Barr, Craig S., Shaik, Naushad, Carter, Nathan, Stoltz, Thomas, Stein, Kenneth M., Brisben, Amy J., Boersma, Lucas V.A.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2020
Assuntos:
Original Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7752215/
https://ncbi.nlm.nih.gov/pubmed/33073614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.120.048728
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados